Toward A Pre-disease State-centered New Paradigm in Multi-omics Research

Area of Science:

• Systems Biology
• Precision Medicine
• Computational Biology

Background:

• Multi-omics data presents challenges in detecting subtle pre-disease signals due to high dimensionality, heterogeneity, and noise.
• Distinguishing reversible metabolic dysregulation from irreversible disease states, like Type 2 Diabetes, is difficult with current analytical methods.
• Existing methods struggle to establish dynamic, causal relationships for predicting disease transitions from health.

Purpose of the Study:

• To propose a novel, pre-disease state-centered research methodology.
• To advance methods for investigating spatiotemporally resolved dynamic processes in biological systems.
• To establish a theoretical foundation for proactive healthcare by decoding pre-disease molecular architecture.

Main Methods:

• Focusing on cross-scale regulatory architectures and multivariate synergistic dynamics.
• Leveraging emerging conceptual, computational, and technological breakthroughs.
• Adopting a systems-level perspective to analyze multi-omics data.

Main Results:

• The proposed methodology offers a novel systems-level window to overcome limitations in current multi-omics studies.
• It facilitates the decoding of the molecular architecture underlying pre-disease states.
• Provides a framework for distinguishing subtle pre-pathological signals from physiological noise.

Conclusions:

• Advocates for a paradigm shift towards a pre-disease state-centered approach.
• Highlights the potential of this methodology as a bridge between multi-omics insights and interceptive medicine.
• Aims to shift clinical action into the pre-symptomatic phase for proactive healthcare.